hotspot -WSS

hotspot

author：leisure time 2025-10-03 00:39:58 - browse：39

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Congress must reauthorize a committee to support older Americans

WSS

J&J to buy cancer drug developer Ambrx Biopharma

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Poor hospice wound care hurts patients and families

In key trial, Verve's treatment lowers cholesterol levels in patients

Anthos stroke drug appears safer than common blood thinner

Burning questions for the 2024 JPM Healthcare Conference

focus

hotspot

focus

Medical leaders decry Supreme Court decision on affirmative action

David Sabatini, ex

In Memoriam: Notable people who died in 2023

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Duchenne breakthrough therapy leaves behind pioneering families

CRISPR pioneers react to Casgevy, first gene

In age of alternative facts, a scholarly course on calling out crap

Morgan Health, with ambitious aims, wants you to know it’s still here

Hollywood unions extend contract negotiations for actors

PBM reforms clear House panel

explore

Wegovy, Zepbound and weight loss drugs that preserve muscle

New weight loss drugs work. But how can they best be used?

UCB departs biotech trade group BIO

Ahead of JPM, here's who's profiting most in health care

David Sabatini, ex

3 trends to watch in health tech's hiring outlook for 2024

entertainment

focus

explore

explore